3 Beaten-Down Stocks With Rebound Potential This Earnings SeasonScholar Rock (NASDAQ:SRRK) said the U.S. Food and Drug Administration has accepted for review its resubmitted Biologics License Application for apitegromab, the company’s investigational treatment for children and ad
3 Beaten-Down Stocks With Rebound Potential This Earnings SeasonScholar Rock (NASDAQ:SRRK) said the U.S. Food and Drug Administration has accepted for review its resubmitted Biologics License Application for apitegromab, the company’s investigational treatment for children and ad
Investing.com -- A federal judge in Washington, D.C., has declined to "rubber-stamp" a $1.5 million settlement between Elon Musk and the U.S. Securities and Exchange Commission (SEC), according to a Friday ruling reported by Reuters.
Investing.com -- A federal judge in Washington, D.C., has declined to "rubber-stamp" a $1.5 million settlement between Elon Musk and the U.S. Securities and Exchange Commission (SEC), according to a Friday ruling reported by Reuters.